Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19.
coronavirus disease 2019 (COVID-19)
coronavirus disease 2019 (COVID-19) fear
coronavirus disease 2019 (COVID-19) knowledge
oncologic care
pandemic
patient education
questionnaire
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
11
06
2020
accepted:
20
07
2020
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) is expected to significantly affect cancer patients due to adverse outcomes with COVID-19 and disruptions in cancer care. Another important point is the stress and anxiety burden of COVID-19, which could affect quality of life. Patient education is vital due to the vulnerability of the topic to disinformation. To determine the areas needing improvements in patient education, and coping with stress, the burden of the problem should be pictured. From this point, we aimed to assess the perspectives and fears of cancer patients about COVID-19 with resources of COVID-19 knowledge with a questionnaire. A total of 250 adult cancer patients applied to the outpatient chemotherapy unit of Hacettepe University Cancer Center between May 27, 2020, and June 9, 2020, invited to answer a questionnaire of 13 multiple-choice questions with a return rate of 78% (195/250). Most patients acquired their knowledge about COVID-19 from television (91.9%). Social media were the second most common source of knowledge (43.8%) with a predilection in younger patients, nonsmokers, targeted therapy- or immunotherapy-treated patients, and breast cancer patients (>65 vs. <65 years of age,
Identifiants
pubmed: 33014800
doi: 10.3389/fonc.2020.01553
pmc: PMC7493662
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1553Informations de copyright
Copyright © 2020 Guven, Sahin, Aktepe, Yildirim, Aksoy and Kilickap.
Références
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
N Engl J Med. 2020 Apr 30;382(18):1677-1679
pubmed: 32109012
Death Stud. 2020;44(7):393-401
pubmed: 32299304
Lancet Oncol. 2020 May;21(5):629-630
pubmed: 32247319
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2020 Jun 11;382(24):2368-2371
pubmed: 32302076
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
JCO Glob Oncol. 2020 May;6:722-729
pubmed: 32412811
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Science. 2020 May 1;368(6490):476-477
pubmed: 32327600
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Acad Emerg Med. 2020 Jul;27(7):640-641
pubmed: 32474977
In Vivo. 2020 Jun;34(3 Suppl):1651-1659
pubmed: 32503825
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Pediatr Blood Cancer. 2020 Jul;67(7):e28318
pubmed: 32240567
Turk J Med Sci. 2020 Apr 17;50(SI-1):563-570
pubmed: 32299206
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052841
ESMO Open. 2020 May;5(Suppl 3):
pubmed: 32439716